David J. Clark
2018 - Aldeyra Therapeutics
In 2018, David J. Clark earned a total compensation of $1.2M as Chief Medical Officer at Aldeyra Therapeutics, a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $133,700 |
|---|---|
| Option Awards | $644,178 |
| Salary | $424,445 |
| Total | $1,202,323 |
Clark received $644.2K in option awards, accounting for 54% of the total pay in 2018.
Clark also received $133.7K in non-equity incentive plan and $424.4K in salary.
Rankings
In 2018, David J. Clark's compensation ranked 8,283rd out of 14,244 executives tracked by ExecPay. In other words, Clark earned more than 41.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,283 out of 14,244 | 42nd |
Division Manufacturing | 3,279 out of 5,762 | 43rd |
Major group Chemicals And Allied Products | 1,229 out of 2,125 | 42nd |
Industry group Drugs | 1,025 out of 1,814 | 44th |
Industry Pharmaceutical Preparations | 798 out of 1,388 | 43rd |
Source: SEC filing on April 22, 2019.
Clark's colleagues
We found three more compensation records of executives who worked with David J. Clark at Aldeyra Therapeutics in 2018.